Eperisone-d10 hydrochloride

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物,专注于信号通路和疾病研究领域。
Eperisone-d10 hydrochloride 

Eperisone-d10 hydrochloride 是 Eperisone hydrochloride 的氘代物。Eperisone hydrochloride ((±)-Eperisone hydrochloride) 是一种抗痉挛试剂,用于肌肉僵硬和疼痛为特征的疾病的相关研究。它通过放松骨骼肌和血管平滑肌来起作用,例如减少肌张力,改善循环和抑制疼痛反射。Eperisone Hydrochloride ((±)-Eperisone hydrochloride) 是一种中枢作用的肌肉松弛剂,抑制疼痛反射通路,具有血管扩张作用。

Eperisone-d10 hydrochloride

Eperisone-d10 hydrochloride Chemical Structure

CAS No. : 1246819-46-4

规格 是否有货
5 mg Check price and availability
50 mg Check price and availability

* Please select Quantity before adding items.

生物活性

Eperisone-d10 ((±)-Eperisone-d10) hydrochloride is the deuterium labeled Eperisone hydrochloride. Eperisone Hydrochloride ((±)-Eperisone hydrochloride) is an antispastic agent used for treatment of diseases characterized by muscle stiffness and pain. It works by relaxing both skeletal muscles and vascularsmooth muscles, thus demonstrating avariety of effects such as reduction ofmyotonia, improvement of circulationand suppression of the pain reflex. Eperisone Hydrochloride ((±)-Eperisone hydrochloride) is a centrally acting muscle relaxant inhibiting the pain reflex pathway, having a vasodilator effect[1][2 [3].

体外研究
(In Vitro)

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

305.91

Formula

C17H16D10ClNO

CAS 号

1246819-46-4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

    [2]. Cabitza P, et al. Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study. Eur Rev Med Pharmacol Sci. 2008 Jul-Aug;12(4):229-35.

    [3]. Frandisco Colomer Rusinvol, et al. Effects of Two Diffferent Doses of Eperisone in the Treatment of Acute Low Back Pain. The Journal of Applied Research.

    [4]. Bavage S, et al. Clinical efficacy and safety of eperisone for low back pain: A systematic literature review. Pharmacol Rep. 2016 Oct;68(5):903-12.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务